Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Natpatou Sanguanwongse
Barriers to and Motivations for the Implementation of a Treatment Programme for Latent Tuberculosis Infection Using Isoniazid for People Living With HIV, in Upper Northern Thailand
Global journal of health science
Medicine
Childhood TB Epidemiology and Treatment Outcomes in Thailand: A TB Active Surveillance Network, 2004 to 2006
BMC Infectious Diseases
Infectious Diseases
Related publications
Implementation of Co-Trimoxazole Prophylaxis and Isoniazid Preventive Therapy for People Living With HIV
Bulletin of the World Health Organization
Environmental
Public Health
Occupational Health
Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Medication Beliefs and Structural Barriers to Treatment Adherence Among People Living With HIV Infection
Psychology and Health
Environmental
Public Health
Applied Psychology
Occupational Health
Optimizing Implementation of Universal HIV Treatment Coverage for People Living With HIV in Senegal
Point-Of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIV
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Tuberculosis Infection and Disease in People Living With HIV in Countries With Low Tuberculosis Incidence
International Journal of Tuberculosis and Lung Disease
Medicine
Pulmonary
Infectious Diseases
Respiratory Medicine
The Impact of Smoking on Adherence to Treatment for Latent Tuberculosis Infection
BMC Public Health
Environmental
Public Health
Occupational Health
The Economic Burden of Tuberculosis and Latent Tuberculosis in People Living With HIV in Brazil: A Cost Study From the Patient Perspective
Public Health
Medicine
Environmental
Public Health
Occupational Health
Treatment Completion for Latent Tuberculosis Infection: A Retrospective Cohort Study Comparing 9 Months of Isoniazid, 4 Months of Rifampin and 3 Months of Isoniazid and Rifapentine
BMC Infectious Diseases
Infectious Diseases
